About: Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1985

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1985 (uk) artículu científicu espublizáu en febreru de 1985 (ast) im Februar 1985 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 February 1985 (en)
publication date	wds:Q69856736-A2E44A2A-8573-4A33-9E51-C25C2639410E
publication date	1985-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69856736-61B45448-9AFC-4712-866A-50A4C7D3A695
language of work or name	English
cites work	wds:Q69856736-106F0000-6D46-48BD-855E-4A1B4B7BC312 wds:Q69856736-672597BB-008F-4017-AD36-63FC08C9044B wds:Q69856736-84CA5BF8-5FDE-438D-A3E0-9EA05740890E wds:Q69856736-9661A204-D6D8-4805-BAFA-E65D66D932D9 wds:Q69856736-9A774E6C-FC05-4EF6-B1AD-537191C14330 wds:Q69856736-A506F3ED-33BB-4747-A0C8-5B5BFC5840A0 wds:Q69856736-BA2B93AD-E848-4E1F-AFAD-7C5F46362B10 wds:Q69856736-FACF5881-1E7B-4E08-8C4A-9ECFB3124C2C
cites work	Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial PHARMACOLOGY OF ANTIPLATELET DRUGS AND CLINICAL TRIALS ON THROMBOSIS PREVENTION: A DIFFICULT LINK Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group Mechanism of Action of Calcium-Channel-Blocking Agents The effects of nifedipine, a calcium antagonist, on platelet function Platelet aggregation studies in whole human blood
author name string	wds:Q69856736-4BEEA6F9-B94D-4F9C-AE7C-E6F321B02D1C wds:Q69856736-A92391D3-59F1-4CAB-ABD9-8D72518C4256 wds:Q69856736-AD04BBF5-6808-4225-9F01-9920369E10BB wds:Q69856736-F7DA638E-BA21-493B-AD7C-6BCF984177F3
author name string	J J Walker I A Greer C D Forbes A A Calder
rdfs:label	Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (en) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (nl) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (sq)
skos:prefLabel	Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (en) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (nl) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (sq)
name	Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (en) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (nl) Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (sq)
title	wds:Q69856736-EABE8ED7-9AB7-4CAB-9F43-D7E1864EEBF3
title	Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis (en)
page(s)	wds:Q69856736-E5A76EC8-B68A-4C58-99C7-5BCEB9623F49
page(s)	351-352
instance of	wds:Q69856736-6D17870F-42EE-4732-BF2F-3B9F5BFDF2EC
instance of	scholarly article
main subject	wds:Q69856736-6B6B4F46-81FF-4F5C-894F-B9C6AB89FB74 wds:Q69856736-76767978-BA4A-4E9B-AF13-831CCD905D9B
main subject	aspirin thrombosis
PubMed ID	wds:Q69856736-EC24573A-13AF-4874-B9AB-8D4A1FCDD1BE
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2857409
PubMed ID	2857409
published in	wds:Q69856736-7799757F-2A85-48E3-9FB0-9A2835A9DE0D
published in	The Lancet
issue	wds:Q69856736-BEE62965-BFA1-4C72-B6D8-502BE0FEB5EA
volume	wds:Q69856736-C7FFEB1A-9902-48FE-AEAE-4FC0B1566622
issue	8424
volume	1
DOI	wds:Q69856736-35A9F036-620E-4C8D-80CD-4F1985D5BAFE
DOI	http://dx.doi.org/10.1016/S0140-6736(85)91133-X
DOI	10.1016/S0140-6736(85)91133-X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69856736
is cites work of	Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders Specific therapy in severe fetal intrauterine growth retardation: failure of prostacyclin. The effects of metoprolol and dazmegrel, alone and in combination, on arrhythmias induced by coronary artery occlusion in conscious rats The low dose aspirin controversy solved at last? Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation. Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial Efficacy of combination antiplatelet therapy and nicardipine for chronic cerebral infarction
is cites work of	wds:Q42572840-473A59F1-BC88-4B29-AA4E-5C01000752DE wds:Q43253671-3DC39603-6D83-4A50-93EE-B407B9F7881B wds:Q39658484-C0C10AF5-CA11-40C2-A296-F3A377EE4B73 wds:Q71584607-A59972D6-0BE8-4DC3-8B72-0564402154F3 wds:Q55129536-99722FBA-23B0-4785-8FDF-2CFB8EBA500F wds:Q45342187-F44BA690-D0EF-47BD-A6A7-284A2BE3BD19 wds:Q43732830-666E0813-4450-4DD7-8A97-7129A25FE8F2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software